Assessing Cognitive Function in Neuromuscular Diseases: A Pilot Study in a Sample of Children and Adolescents
Authors:
- Rossella D’alessandroRDRossella D’alessandro
- Neftj RagusaNRNeftj Ragusa
- Martina VacchettiMVMartina Vacchetti
- Enrica RolleEREnrica Rolle
- Francesca RossiFRFrancesca Rossi
- Chiara BrusaCBChiara Brusa
- Chiara DavicoCDChiara Davico
- Benedetto VitielloBVBenedetto Vitiello
- Tiziana MonginiTMTiziana Mongini
- Federica S. RicciFRFederica S. Ricci
Open Access
- 18 October 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (20) , 4777
Abstract
Central nervous system (CNS) involvement has been variously studied in pediatric neuromuscular disorders (NMDs). The primary goal of this study was to assess cognitive functioning in NMDs, and secondary aims were to investigate possible associations of cognitive impairment with motor impairment, neurodevelopmental delay, and genotype. This was a cross-sectional study of 43 pediatric patients, affected by six NMDs. Myotonic dystrophy type 1 (DM1) and glycogen storage disease type 2 (GSD2) patients had a delay on the Bayley-III scales. On Wechsler scales, DMD and DM1 patients showed lower FSIQ scores, with an intellectual disability (ID) in 27% and 50%, respectively. FSIQ was normal in Becker muscular dystrophy (BMD), GSD2, and hereditary motor sensory neuropathy (HMSN) patients, while higher individual scores were found in the spinal muscular atrophy (SMA) group. In the DM1 cohort, lower FSIQ correlated with worse motor performance (ρ = 0.84, p < 0.05), and delayed speech acquisition was associated with ID (p = 0.048), with worse cognitive impairment in the congenital than in the infantile form (p = 0.04). This study provides further evidence of CNS in some NMDs and reinforces the need to include cognitive assessment in protocols of care of selected pediatric NMDs.Keywords
This publication has 38 references indexed in Scilit:
- Central nervous system abnormalities in patients with PMP22 gene mutations: a prospective studyJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Neurocognitive Profiles in Duchenne Muscular Dystrophy and Gene Mutation SitePediatric Neurology, 2011
- A new window on neurocognitive dysfunction in the childhood form of myotonic dystrophy type 1 (DM1)Neuromuscular Disorders, 2011
- Dystrophin and the brainDevelopmental Medicine & Child Neurology, 2010
- Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-UpPLOS ONE, 2009
- Cognitive and Psychological Profile of Males With Becker Muscular DystrophyJournal of Child Neurology, 2007
- Cognitive impairment in neuromuscular disordersMuscle & Nerve, 2006
- Intelligence and Duchenne muscular dystrophy: Full-Scale, Verbal, and Performance intelligence quotientsDevelopmental Medicine & Child Neurology, 2001
- A study of the cognitive and psychological profile in 16 children with congenital or juvenile myotonic dystrophyClinical Genetics, 1997
- Cognitive deficits and personality patterns in maternally versus paternally inherited myotonic dystrophyJournal of Clinical and Experimental Neuropsychology, 1994